Clinical Trials Logo

t(11;14) Positive clinical trials

View clinical trials related to t(11;14) Positive.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03872180 Active, not recruiting - Clinical trials for Mantle Cell Lymphoma

Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

Start date: April 11, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well bendamustine, obinutuzumab, and venetoclax work in treating patients with mantle cell lymphoma. Drugs used in chemotherapy, such as bendamustine and venetoclax, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving bendamustine, obinutuzumab, and venetoclax may work better in treating patients with mantle cell lymphoma.